Zeta Surgical: Difference between revisions
Writer409400 (talk | contribs) m Corrected redundant reference to FDA. |
|||
Line 14: | Line 14: | ||
'''Zeta Surgical''' is a privately held American [[medical technology]] company based in [[Boston]], [[Massachusetts]]. The company develops [[computer-assisted surgery]] systems for [[neurosurgery]] and [[interventional neuroradiology]]. The company was founded in 2018 by [[Harvard University]] graduates Jose Amich and Raahil Sha, along with [[Brigham and Women's Hospital]] neurosurgeon William Gormley.<ref name="fiercebiotech2023" /><ref name="forbes2023" /> |
'''Zeta Surgical''' is a privately held American [[medical technology]] company based in [[Boston]], [[Massachusetts]]. The company develops [[computer-assisted surgery]] systems for [[neurosurgery]] and [[interventional neuroradiology]]. The company was founded in 2018 by [[Harvard University]] graduates Jose Amich and Raahil Sha, along with [[Brigham and Women's Hospital]] neurosurgeon William Gormley.<ref name="fiercebiotech2023" /><ref name="forbes2023" /> |
||
==Technology== |
==Technology== |
||
Zeta Surgical's technology employs [[computer vision]] and [[artificial intelligence]] algorithms for real-time surgical navigation. The company's approach utilizes [[parallel computing]] for [[image registration]] and patient tracking without rigid head fixation. Preclinical studies have evaluated |
Zeta Surgical's technology employs [[computer vision]] and [[artificial intelligence]] algorithms for real-time surgical navigation. The company's approach utilizes [[parallel computing]] for [[image registration]] and patient tracking without rigid head fixation. Preclinical studies have evaluated the system's ability to maintain submillimeter accuracy in applications such as [[neurotrauma]], [[intracerebral hemorrhage]] and [[brain biopsy]].<ref name="chiurillo2023" /><ref name="robertson2021" /><ref name="robertson2022" /> |
||
The company's primary product, the Zeta Cranial Navigation System, has been described as a "GPS-like" system for neurosurgery.<ref name="fiercebiotech2023" /> It received |
The company's primary product, the Zeta Cranial Navigation System, has been described as a "GPS-like" system for neurosurgery.<ref name="fiercebiotech2023" /> It received 510(k) clearance from the US [[Food and Drug Administration]] for use in cranial surgical procedures in September 2023.<ref name="fda2023a" /><ref name="fda2023b" /><ref name="bbj2023" /> In 2024, Zeta Surgical reported the completion of its first multi-center trial at [[Singapore General Hospital]] and [[Tan Tock Seng Hospital]].<ref name="mdn2024" /> The Zeta Cranial Navigation System received an [[iF Design Award]] and a Good Design Award in 2023.<ref name="ifdesign2023" /><ref name="gooddesign2023" /> The company is partnered with Australian product design and consultancy firm Design + Industry.<ref name="designindustry" /> |
||
In 2022, Zeta Surgical announced that it was developing a [[Focused ultrasound for intracranial drug delivery]] system, navigated by the Zeta Cranial Navigation System. <ref name="aithority2024" /> The company is a member of the [[Focused Ultrasound Foundation]].<ref name="fusf2024" /> |
In 2022, Zeta Surgical announced that it was developing a [[Focused ultrasound for intracranial drug delivery]] system, navigated by the Zeta Cranial Navigation System. <ref name="aithority2024" /> The company is a member of the [[Focused Ultrasound Foundation]].<ref name="fusf2024" /> |
Revision as of 18:29, 2 September 2024
Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources Last edited by Writer409400 (talk | contribs) 2 months ago. (Update) |
Company type | Private |
---|---|
Industry | Medical devices |
Founded | 2018 |
Founders | Jose Amich (CEO), Raahil Sha (CTO), William Gormley |
Headquarters | Boston, Massachusetts, United States |
Products | Surgical navigation |
Website | https://zetasurgical.com |
Zeta Surgical is a privately held American medical technology company based in Boston, Massachusetts. The company develops computer-assisted surgery systems for neurosurgery and interventional neuroradiology. The company was founded in 2018 by Harvard University graduates Jose Amich and Raahil Sha, along with Brigham and Women's Hospital neurosurgeon William Gormley.[1][2]
Technology
Zeta Surgical's technology employs computer vision and artificial intelligence algorithms for real-time surgical navigation. The company's approach utilizes parallel computing for image registration and patient tracking without rigid head fixation. Preclinical studies have evaluated the system's ability to maintain submillimeter accuracy in applications such as neurotrauma, intracerebral hemorrhage and brain biopsy.[3][4][5]
The company's primary product, the Zeta Cranial Navigation System, has been described as a "GPS-like" system for neurosurgery.[1] It received 510(k) clearance from the US Food and Drug Administration for use in cranial surgical procedures in September 2023.[6][7][8] In 2024, Zeta Surgical reported the completion of its first multi-center trial at Singapore General Hospital and Tan Tock Seng Hospital.[9] The Zeta Cranial Navigation System received an iF Design Award and a Good Design Award in 2023.[10][11] The company is partnered with Australian product design and consultancy firm Design + Industry.[12]
In 2022, Zeta Surgical announced that it was developing a Focused ultrasound for intracranial drug delivery system, navigated by the Zeta Cranial Navigation System. [13] The company is a member of the Focused Ultrasound Foundation.[14]
History
Zeta Surgical was started by Jose Amich and Raahil Sha while studying as undergraduate students at Harvard University, together with Harvard Medical School professor William Gormley, also a neurosurgeon at the Brigham and Women's Hospital.[15] Jose Amich and William Gormley are alumni of the MIT Sloan School of Management MBA program.[16][17] The company has raised funding from notable investors such as Y Combinator, Artesian Hostplus VC, Innospark Ventures, Trevor Fetter, Gabriel Hammond and Marc de Garidel.[18][15] Zeta Surgical is represented by law firm White & Case LLP.[19]
Raahil Sha was named one of Harvard's Most Interesting Seniors.[20] Together with Jose Amich, they have been recognized on the North American Forbes 30 Under 30 2024 list.[2]
References
- ^ a b Park, Andrea (13 September 2023). "Zeta Surgical zeroes in on FDA nod for 'GPS-like' neurosurgery navigation system". Fierce Biotech. Retrieved 13 June 2024.
Zeta Surgical is zeroing in on an FDA clearance for its GPS-like neurosurgery navigation system
- ^ a b "30 Under 30 North America: Jose Amich and Raahil Sha". Forbes. 28 November 2023. Retrieved 13 June 2024.
- ^ Chiurillo, I.; Sha, R. M.; Robertson, F. C. (2023). "High-Accuracy Neuro-Navigation with Computer Vision for Frameless Registration and Real-Time Tracking". Bioengineering. 10 (12): 1401. doi:10.3390/bioengineering10121401.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - ^ Robertson, F. C.; Sha, R. M.; Amich, J. M. (2021). "Frameless neuronavigation with computer vision and real-time tracking for bedside external ventricular drain placement: a cadaveric study". Journal of Neurosurgery. 136 (5): 1475–1484. doi:10.3171/2021.5.JNS211033.
- ^ Robertson, F. C.; Wu, K. C.; Sha, R. M. (2022). "Stereotactic Neurosurgical Robotics With Real-Time Patient Tracking: A Cadaveric Study". Operative Neurosurgery. 22 (6): 425–432. doi:10.1227/ons.0000000000000155.
- ^ "510(k) Premarket Notification". U.S. Food and Drug Administration. 11 September 2023. Retrieved 13 June 2024.
- ^ "510(k) Premarket Notification". U.S. Food and Drug Administration. 11 January 2024. Retrieved 13 June 2024.
- ^ "Zeta Surgical secures first FDA clearance for robotic surgery system". Boston Business Journal. 11 September 2023. Retrieved 13 June 2024.
- ^ "Zeta Surgical sees positive results in guided neurosurgery trial". Medical Device Network. 7 June 2024. Retrieved 13 June 2024.
- ^ "Zeta Cranial Navigation System". iF Design Award. 2023. Retrieved 13 June 2024.
- ^ "Zeta Surgical Neurosurgical Navigation System". Good Design Award. 2023. Retrieved 13 June 2024.
- ^ "Zeta Surgical". Design + Industry. Retrieved 13 June 2024.
- ^ AiThority (22 January 2024). "Zeta Surgical Appoints Professor James Choi as Focused Ultrasound Lead in Push for Incision-Less Brain Surgery". AiThority. Retrieved 13 June 2024.
- ^ "State of the Field Report 2024: Chapter 8 - FUS Industry" (PDF). Focused Ultrasound Foundation. July 2024. Retrieved 13 June 2024.
- ^ a b "Emles Venture Partners". Retrieved 13 June 2024.
- ^ "Forbes 30 Under 30 List Spotlights 35 from MIT". MIT Alumni Association. Retrieved 13 June 2024.
- ^ "Clinical and Scientific Advisors". CoaguloMed. Retrieved 13 June 2024.
- ^ "Zeta Surgical comes out of stealth with a $5.2M raise for image-guided surgery". TechCrunch. 10 March 2022. Retrieved 13 June 2024.
- ^ "White & Case Advises Zeta Surgical Inc. on Preferred Stock Financing". White & Case LLP. 5 March 2024. Retrieved 13 June 2024.
- ^ "The Most Interesting Seniors in the Harvard Class of 2018". The Harvard Crimson. 21 June 2018. Retrieved 13 June 2024.